Diffuse astrocytoma
MONDO:0016686A low-grade (WHO grade II) astrocytic neoplasm. It is characterized by diffuse infiltration of neighboring central nervous system structures. These lesions typically affect young adults and have a tendency for progression to anaplastic astrocytoma and glioblastoma. Based on the IDH genes mutation status, diffuse astrocytomas are classified as IDH-mutant, IDH-wildtype, and not otherwise specified.
Also known as: WHO grade II astrocytoma, astrocytoma, diffuse, astrocytoma, diffuse, malignant, diffuse astrocytoma, grade II astrocytic neoplasm, grade II astrocytic tumor, grade II astrocytic tumour, grade II astrocytoma
1477 clinical trials for this condition and its sub-types, 25 tagged with Diffuse astrocytoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Diffuse astrocytoma
-
Fibrillary astrocytoma 3 trials
-
Gemistocytic astrocytoma 0 trials
-
Protoplasmic astrocytoma 0 trials
-
AI reads MRI scans to spot brain tumors without surgery
Diagnosis CompletedThis study tests whether an artificial intelligence system called GliomaAI-Astro23 can identify a specific type of brain tumor (IDH mutant astrocytoma) from routine MRI scans. Researchers are using existing MRI data from 1,372 patients to train and evaluate the AI. If accurate, t…
Sponsor: Deep Learning Institute of Radiological Sciences • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
Can stress shorten life in brain cancer? new study investigates
Knowledge-focused CompletedThis completed study looked at whether stress and exercise levels influence survival and quality of life in 42 people with glioblastoma, a severe brain cancer. Participants wore a smartwatch to track heart rate, sleep, and activity, and filled out questionnaires on stress and fat…
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New brain scan could sharpen surgery for glioma patients
Knowledge-focused CompletedThis pilot study tested whether a special PET scan using 18F-FDOPA can help doctors better plan surgery and radiation for people with newly diagnosed brain tumors (gliomas). Twenty-four adults took part at Mayo Clinic. The goal was to see if the scan provides useful information b…
Early phase 1 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:06 UTC